Author

Marie Enajite Diegbe

Institution: Janssen (Netherlands)

Observed institution: Janssen (Netherlands)

OpenAlex ID: A5107762688

Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical Trial

2024 · Veronica V. Rezelj, Fred Paddenburg, et al. · Vaccines · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: